Key facts
- It has raised $9.2M; the latest was Seed Round ($5.7M) in Nov 2024.
- Notable investors include SyndicateRoom, Cambridge Angels, UK Innovation & Science Seed Fund, Dhuna Ventures, ACF Investors — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Silveray
- ·The full record, as it builds
Funding rounds
No funding rounds for Silveray are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Silveray
Developer of direct conversion detectors designed to replace radiographic film used in the industrial inspection of critical welds with a digital solution. The company offers X-ray imaging performance and nanoparticle-based X-ray conversion material produced as a semiconductor ink and deposited onto a pixel backplane, enabling healthcare industries to create an electrical current response to the detected X-ray photon at a sustainable cost point.
- Sector
- Healthcare
- HQ
- Stockport, United Kingdom
- Founded
- 2018
- Employees
- 13
- Website
- silveray.co.uk/
- Ownership
- Privately Held (backing)
Silveray doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Silveray shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Silveray in its N-PORT filings yet. We sweep new filings monthly.